Toxicology – Hypotension and Shock

Definition

Hypotension is blood pressure that is abnormally low for the patient’s age and physiologic state.

In adults, systolic BP <90 mm Hg or mean arterial pressure (MAP) <65 mm Hg is commonly used as a practical warning threshold, but a single numerical cutoff does not define adequate circulation.

Shock means inadequate tissue perfusion and oxygen delivery, which may occur with or without marked hypotension.

Signs of impaired perfusion include:

• Altered mental status
• Cool or mottled extremities
• Delayed capillary refill
• Weak peripheral pulses
• Oliguria
• Elevated lactate
• Metabolic acidosis

Pathophysiology

Toxicologic hypotension can result from several mechanisms:

1. Myocardial depression

• Beta-blockers
• Calcium-channel blockers
• Some sodium-channel blockers

2. Vasodilation

• Alpha-adrenergic blockade
• Sedative agents
• Vasodilators
• Severe distributive toxicity

3. Bradycardia or conduction failure

• Beta-blockers
• Calcium-channel blockers
• Digoxin
• Cholinergic agents
• Clonidine/imidazolines

4. Dysrhythmias

• Sodium-channel blockers
• Digoxin
• Sympathomimetics
• Theophylline

5. Hypovolemia

• Vomiting/diarrhea
• Hemorrhage
• Excessive sweating
• Third-spacing or capillary leak

6. Hypoxia or metabolic derangement

• Severe hypoxemia
• Acidosis
• Electrolyte abnormalities
• Hypothermia

Several mechanisms may occur simultaneously.

Major Toxicologic Causes

Important causes include:

• Beta-blockers
• Calcium-channel blockers
• Digoxin and other cardiac glycosides
• Tricyclic antidepressants and other sodium-channel blockers
• Clonidine and imidazolines
• Opioids
• Sedative-hypnotics
• Organophosphates/carbamates
• Iron
• Theophylline
• Severe sympathomimetic poisoning
• Vasodilators

Beta-Blocker Toxicity

Typical findings include:

• Hypotension
• Bradycardia
• AV block
• Reduced myocardial contractility
• CNS depression

Some beta-blockers can additionally cause:

• Seizures
• QRS widening
• Ventricular dysrhythmias

Hypoglycemia can occur, particularly in children or severe poisoning.

The source’s association of beta-blocker poisoning with hyperglycemia is less characteristic; hyperglycemia is a more useful clue to calcium-channel blocker toxicity.

Calcium-Channel Blocker Toxicity

Severe poisoning can produce:

• Hypotension
• Bradycardia
• AV block
• Myocardial depression
• Vasodilation
• Shock

Hyperglycemia is an important diagnostic clue because calcium-channel blockade impairs pancreatic insulin release.

Severe cases can progress to profound cardiogenic and vasodilatory shock.

Digoxin Toxicity

Possible findings include:

• Nausea/vomiting
• Bradycardia
• AV block
• Ventricular dysrhythmias
• Visual disturbances
• Hypotension

Acute severe poisoning may produce hyperkalemia.

Digoxin immune Fab is the definitive antidote for life-threatening cardiac glycoside toxicity.

Clonidine and Imidazolines

These can produce:

• CNS depression
• Miosis
• Bradycardia
• Hypotension
• Respiratory depression

A brief initial hypertensive phase may precede hypotension.

This presentation can closely resemble opioid poisoning.

Opioids

The classic toxidrome includes:

• CNS depression
• Respiratory depression
• Miosis

Hypotension can develop in severe poisoning, especially with:

• Hypoxia
• Vasodilation
• Coingestants

When opioid-induced respiratory depression is suspected, naloxone is indicated, with the goal of restoring adequate ventilation rather than necessarily complete consciousness.

Cholinergic Poisoning

Organophosphate and carbamate poisoning may produce:

• Miosis
• Salivation
• Lacrimation
• Sweating
• Bronchorrhea
• Bronchospasm
• Vomiting/diarrhea
• Bradycardia
• Hypotension

Nicotinic effects include:

• Fasciculations
• Weakness
• Paralysis

Severe hypotension may accompany respiratory failure and profound cholinergic toxicity.

Sodium-Channel Blockade

Tricyclic antidepressants are the classic example.

Findings include:

• Hypotension
• Tachycardia
• CNS depression
• Seizures
• QRS widening
• Ventricular dysrhythmias

An ECG showing QRS widening and a prominent terminal R wave in aVR supports significant sodium-channel blockade.

Sodium bicarbonate is a key treatment for clinically important TCA/sodium-channel-blocking cardiotoxicity.

Iron Poisoning

Severe iron toxicity can produce:

• Vomiting
• Abdominal pain
• GI bleeding
• High-anion-gap metabolic acidosis
• CNS depression
• Hypotension/shock
• Hepatic injury

Shock may result from GI fluid loss, vasodilation, mitochondrial toxicity, and cardiovascular dysfunction.

Sympathomimetics

Cocaine and amphetamine-type stimulants usually initially cause:

• Hypertension
• Tachycardia
• Agitation
• Hyperthermia

Severe poisoning can later progress to hypotension from:

• Dysrhythmias
• Myocardial ischemia/dysfunction
• Severe hyperthermia
• Acidosis
• Volume depletion
• Cardiovascular collapse

Clinical Clues

Hypotension + bradycardia + hyperglycemia

→ consider calcium-channel blocker toxicity

Hypotension + bradycardia + CNS depression ± hypoglycemia

→ consider beta-blocker toxicity

Hypotension + miosis + respiratory depression

→ opioid or clonidine/imidazoline toxicity

Hypotension + miosis + bronchorrhea + secretions

→ cholinergic syndrome

Hypotension + QRS widening + seizures

→ sodium-channel blocker toxicity

Hypotension + dysrhythmia + GI symptoms + hyperkalemia

→ consider digoxin toxicity

Nontoxicologic Causes

Do not assume hypotension is caused by poisoning.

Important alternatives include:

• Sepsis
• Hemorrhage
• Dehydration
• Myocardial infarction
• Pulmonary embolism
• Cardiac tamponade
• Tension pneumothorax
• Anaphylaxis
• Spinal/neurogenic shock
• Adrenal crisis
• Hypothermia

Evaluation

Immediate assessment should focus on:

• Airway
• Breathing
• Circulation
• Mental status
• Peripheral perfusion
• Urine output
• Temperature

Important investigations include:

• ECG
• Continuous cardiac monitoring
• Bedside glucose
• Electrolytes
• Renal function
• Acid-base assessment when indicated

Depending on presentation:

• Lactate
• Troponin
• Creatine kinase
• Digoxin concentration
• Acetaminophen/salicylate concentrations
• Bedside ultrasound/echocardiography
• Other targeted toxicology tests

Routine urine toxicology screens have limited ability to identify the cause of shock.

ECG

ECG findings can provide major diagnostic clues.

Look for:

• Bradycardia
• AV block
• QRS widening
• QT prolongation
• Ventricular dysrhythmias
• Myocardial ischemia

Continuous monitoring is appropriate in significant poisoning-associated hypotension.

Initial Management

Management follows standard resuscitation priorities:

• Ensure adequate airway and ventilation.
• Provide oxygen when indicated.
• Establish vascular access.
• Obtain continuous cardiac monitoring.
• Check glucose.
• Correct major electrolyte abnormalities.
• Treat seizures, hypoxia, and severe temperature abnormalities.
• Identify and treat the responsible toxicant.

Endotracheal intubation is based on failure of oxygenation/ventilation or inability to protect the airway, not hypotension alone.

IV Fluids

Isotonic crystalloid may be appropriate when:

• Hypovolemia is suspected
• There is no evidence of major fluid overload

However, repeated large fluid boluses may be harmful when the dominant problem is drug-induced myocardial depression.

Fluid therapy should therefore be individualized using:

• Clinical perfusion
• Lung examination
• Urine output
• Bedside ultrasound when available
• Hemodynamic response

Vasopressors

Persistent shock despite appropriate initial measures generally requires vasopressor therapy.

Norepinephrine is commonly used for vasodilatory shock and is often a preferred initial vasopressor in undifferentiated severe hypotension.

The optimal agent can differ according to the poison and mechanism.

The source’s routine sequence of dopamine followed by norepinephrine is outdated; dopamine is no longer the universal first-line vasopressor for poisoned hypotensive patients.

High-Dose Insulin Euglycemia Therapy

High-dose insulin therapy is an important treatment for severe:

• Calcium-channel blocker poisoning
• Beta-blocker poisoning

It improves myocardial energy utilization and contractility.

Close monitoring is required for:

• Hypoglycemia
• Hypokalemia
• Fluid and glucose requirements

Calcium

IV calcium is particularly useful in calcium-channel blocker toxicity.

It may temporarily improve:

• Contractility
• Blood pressure
• Cardiac conduction

Because the effect may be incomplete or temporary, severe poisoning often requires additional therapies.

Glucagon

Glucagon can improve heart rate and contractility in beta-blocker poisoning by increasing intracellular cAMP through a receptor independent of the beta-adrenergic receptor.

It may be used as an adjunct, although modern severe beta-blocker poisoning management frequently relies heavily on vasopressors and high-dose insulin therapy.

Sodium Bicarbonate

Sodium bicarbonate is indicated for clinically important cardiac sodium-channel blockade, particularly when there is:

• QRS widening
• Ventricular dysrhythmia
• Significant hypotension attributable to sodium-channel blockade

TCAs are the classic cause.

Atropine and Pacing

Atropine may be attempted for symptomatic bradycardia.

However, it may be ineffective in severe:

• Beta-blocker poisoning
• Calcium-channel blocker poisoning
• Digoxin toxicity

Temporary cardiac pacing may be considered in selected refractory bradyarrhythmias.

A limitation is that pacing can increase the heart rate without correcting severe myocardial contractile failure, so blood pressure may remain poor.

Refractory Toxicologic Shock

When shock remains severe despite conventional treatment, options depend on the toxicant and may include:

• Additional vasopressors
• High-dose insulin
• Specific antidotes
• Intravenous lipid emulsion in selected poisonings
• Extracorporeal toxin removal for appropriate dialyzable substances
• VA-ECMO/mechanical circulatory support for selected potentially reversible poisonings with refractory cardiovascular collapse

Early toxicology and critical-care consultation is important.

Decontamination

Do not induce vomiting.

Routine gastric lavage in hypotensive poisoned patients is not standard modern practice and may create additional risk.

Activated charcoal may be considered after selected ingestions only when:

• Meaningful benefit is expected
• GI function is adequate
• The airway is protected

Resuscitation always takes priority over gastrointestinal decontamination.

Monitoring

Patients with significant toxicologic hypotension require:

• Continuous ECG monitoring
• Frequent blood-pressure assessment
• Serial perfusion examinations
• Glucose monitoring
• Electrolyte and renal-function monitoring
• Assessment of urine output
• Serial lactate when useful

An arterial catheter may be helpful in severe shock requiring titrated vasoactive therapy.

Key Points

• Hypotension is a blood-pressure finding; shock means inadequate tissue perfusion.
• The severity of poisoning should not be judged by blood pressure alone.
• Toxicologic mechanisms include myocardial depression, vasodilation, bradycardia, dysrhythmias, and hypovolemia.
• Bradycardia + hyperglycemia → consider calcium-channel blocker poisoning.
• Bradycardia + CNS depression ± hypoglycemia → consider beta-blocker poisoning.
• Miosis + respiratory depression → consider opioids or clonidine.
• QRS widening + hypotension/seizures → consider sodium-channel blockade, particularly TCAs.
• Acute digoxin poisoning can produce hyperkalemia and dysrhythmias; severe cases require digoxin immune Fab.
• Fluids are useful when hypovolemia is present but excessive volume can worsen drug-induced myocardial failure.
• Norepinephrine is commonly preferred over the older routine dopamine-first approach for persistent shock.
• High-dose insulin therapy is important in severe CCB and beta-blocker poisoning.
• Sodium bicarbonate is central to significant sodium-channel blocker cardiotoxicity.
• Refractory, potentially reversible toxicologic cardiovascular collapse may require VA-ECMO or other advanced circulatory support.